AstraZeneca Vaccine Doses Ready for Use as Canada Approves U.S. Manufacturing Sites

A pharmacist shows off a vial of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist during the COVID-19 pandemic in Toronto on March 12, 2021. Nathan Denette / The Canadian Press

OTTAWA—More than 1.5 million doses of the Oxford-AstraZeneca vaccine are on their way to provinces now that Health Canada has authorized the U.S. sites where they were made.

It remains to be seen how many Canadians will be eager to get them, as part of the fallout from Monday’s decision to pause the use of the AstraZeneca vaccine for anyone under the age of 55 pending more analysis on the risk of blood clots.